 |
| Metformin 500mg tablets (Photo credit: Wikipedia) |
A common diabetes drug may slow another malignancy: ovarian cancer.
Ovarian cancer patients who were taking
metformin at the time of their diagnosis survived longer than patients
who weren't on the drug, a new study by Mayo Clinic researchers shows.
Metformin goes by the brand name Glucophage
and is derived from French lilacs. It's typically prescribed to lower
blood sugar levels in people with type 2 diabetes but has shown promise
as a potential anticancer agent in recent prostate, colon, pancreas,
brain, and breast cancer studies, as well as in lab experiments with
ovarian cancer cells.
No comments:
Post a Comment